These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Intravesical ethoglucid (Epodyl) for treatment of noninvasive bladder cancer (stage Ta). Larson A; Fritjofsson A Ups J Med Sci; 1985; 90(2):127-32. PubMed ID: 3909592 [TBL] [Abstract][Full Text] [Related]
48. [Treatment of stage Ta,T1 and Tis bladder tumors using Calmette-Guérin bacillus vaccine]. Bretheau D; Lechevallier E; Rossi D; Albert P; de Fromont M; Coulange C Prog Urol; 1993; 3(4):608-17. PubMed ID: 8401621 [TBL] [Abstract][Full Text] [Related]
49. Ta and T1 bladder cancer: location, recurrence and progression. Heney NM; Nocks BN; Daly JJ; Prout GR; Newall JB; Griffin PP; Perrone TL; Szyfelbein WA Br J Urol; 1982 Apr; 54(2):152-7. PubMed ID: 7082932 [TBL] [Abstract][Full Text] [Related]
50. [Mitoxantrone chemoprophylaxis for multirecurrent multifocal superficial bladder tumours: results of a phase 2 controlled study]. Bassi PF; Spinadin R; Carando R; Dal Moro F; Abatangelo G; Piazza N; Tavolini IM Arch Ital Urol Androl; 2003 Dec; 75(4):202-4. PubMed ID: 15005494 [TBL] [Abstract][Full Text] [Related]
51. [Prognosis of superficial urothelial tumors of the bladder. Evaluation possibilities using the erythrocyte adherence test (SRCA test)]. Krüger R; Reuter F; Deilmann W Pathologe; 1982 Sep; 3(5):266-71. PubMed ID: 7145864 [No Abstract] [Full Text] [Related]
52. Value of random mucosal biopsies in the management of superficial bladder cancer. Mufti GR; Singh M Eur Urol; 1992; 22(4):288-93. PubMed ID: 1490505 [TBL] [Abstract][Full Text] [Related]
53. [Transabdominal and transurethral scanning in the diagnosis of the bladder cancer stage]. Stepanov VN; Perel'man VM; Abdukhakimov AF Urol Nefrol (Mosk); 1991; (2):33-7. PubMed ID: 2063502 [TBL] [Abstract][Full Text] [Related]
55. [Therapy and follow-up of bladder cancer]. Meyer D; Schmid HP; Engeler DS Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413 [TBL] [Abstract][Full Text] [Related]
56. [Course of superficial carcinoma of bladder (Ta-T1). Apropos of 171 cases]. Novak R J Urol (Paris); 1987; 93(1):21-4. PubMed ID: 3559256 [TBL] [Abstract][Full Text] [Related]
57. The value of a second transurethral resection in evaluating patients with bladder tumours. Miladi M; Peyromaure M; Zerbib M; Saïghi D; Debré B Eur Urol; 2003 Mar; 43(3):241-5. PubMed ID: 12600426 [TBL] [Abstract][Full Text] [Related]
58. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study. Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125 [TBL] [Abstract][Full Text] [Related]
59. [Value of imaging procedures in the diagnosis and staging of bladder tumors]. Nicolas V; Harder T; Steudel A; Krahe T; Schindler G; van Ahlen H; Jaeger N Rofo; 1988 Mar; 148(3):234-9. PubMed ID: 2832883 [TBL] [Abstract][Full Text] [Related]